Brief: Star Combo Pharma To Acquire 100% Of Shares In Bio-E For A$60Mln
July 8 (Reuters) - Star Combo Pharma Ltd S66.AX :
* ENTERED INTO AN AGREEMENT TO ACQUIRE 100% OF SHARES IN
BIO-E FOR
UPFRONT CONSIDERATION OF A$60M
* UPFRONT CONSIDERATION COMPRISES A CASH PAYMENT OF A$42M
PLUS
ISSUE OF 30M STAR COMBO SHARES AT A$0.60 PER SHARE
* CASH CONSIDERATION TO BE FUNDED VIA A CAPITAL RAISING OF
A$51M
* ISSUE PRICE OF A$0.56 PER SHARE
Source text for Eikon: ID:nASX8Y4mxC
Further company coverage: S66.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Star Combo Pharma
See all newsBrief: Star Combo Pharma Announces Insurance Claim Settlement Of A$5 Million
Brief: Star Combo Pharma Says Outlook For FY2025 Is Positive
Brief: Star Combo Pharma Says HY Operating Loss Attributable A$4.4 Million
Brief: Star Combo Pharma Posts Q1 Fy23 Revenue Of A$6.55M
Australia's Star Combo Pharma plunges to record low on fire incident